GAMMA Investing’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.6K Buy
1,939
+1,843
+1,920% +$12.1K ﹤0.01% 3055
2026
Q2
$547 Buy
+96
New +$415 ﹤0.01% 3975
2024
Q3
– Sell
-204
Closed -$322 – 3641
2024
Q2
$322 Hold
204
– – ﹤0.01% 3270
2024
Q1
$296 Hold
204
– – ﹤0.01% 3182
2023
Q4
$282 Buy
+204
New +$240 ﹤0.01% 3084

Other funds holding PGEN

GAMMA Investing's PGEN Position: Q3 2026 in Review

GAMMA Investing increased its Precigen (PGEN) stake by 1,920% in Q3 2026, buying an estimated $12.1K and bringing the position to 1,939 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

GAMMA Investing first reported a position in PGEN in Q4 2023 and has held it in 5 quarters since. 8 funds tracked by Wall St. Rank hold PGEN as of Q3 2026.

  • GAMMA Investing held 1,939 shares of Precigen worth $16.6K as of Q3 2026.
  • GAMMA Investing bought 1,843 Precigen shares in Q3 2026, an estimated $12.1K.
  • Precigen made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3055 holding.
  • GAMMA Investing first reported a position in Precigen in Q4 2023 and has held it in 5 quarters since.
  • 8 funds tracked by Wall St. Rank held Precigen as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.